340 related articles for article (PubMed ID: 9164182)
21. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
[TBL] [Abstract][Full Text] [Related]
23. Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphoma.
Richards MA; Webb JA; Jewell SE; Amess JA; Wrigley PF; Lister TA
Br J Cancer; 1988 Apr; 57(4):412-5. PubMed ID: 3390376
[TBL] [Abstract][Full Text] [Related]
24. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA
Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874
[TBL] [Abstract][Full Text] [Related]
25. Value of 18F-FDG PET versus iliac biopsy in the initial evaluation of bone marrow infiltration in the case of Hodgkin's disease: a meta-analysis.
Cheng G; Alavi A
Nucl Med Commun; 2013 Jan; 34(1):25-31. PubMed ID: 23111383
[TBL] [Abstract][Full Text] [Related]
26. [MR tomography detection of bone marrow infiltration by malignant lymphomas].
Gückel F; Döhner H; Knauf W; Ho AD; Semmler W; van Kaick G
Onkologie; 1989 Aug; 12 Suppl 1():34-7. PubMed ID: 2685693
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
[TBL] [Abstract][Full Text] [Related]
28. Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies.
Iizuka-Mikami M; Nagai K; Yoshida K; Sugihara T; Suetsugu Y; Mikami M; Tamada T; Imai S; Kajihara Y; Fukunaga M
Eur Radiol; 2004 Jun; 14(6):1074-81. PubMed ID: 14986048
[TBL] [Abstract][Full Text] [Related]
29. MR detection of iliac bone marrow involvement by malignant lymphoma with various MR sequences including diffusion-weighted echo-planar imaging.
Yasumoto M; Nonomura Y; Yoshimura R; Haraguchi K; Ito S; Ohashi I; Shibuya H
Skeletal Radiol; 2002 May; 31(5):263-9. PubMed ID: 11981602
[TBL] [Abstract][Full Text] [Related]
30. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Eur J Haematol; 2015 Jul; 95(1):83-9. PubMed ID: 25537478
[TBL] [Abstract][Full Text] [Related]
31. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases.
Widding A; Smolorz J; Franke M; Linden A; Diehl V; Schicha H
Eur J Nucl Med; 1989; 15(5):230-8. PubMed ID: 2503382
[TBL] [Abstract][Full Text] [Related]
33. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow in pediatric patients with Hodgkin's disease.
Khan FS; Hasan RF
J Ayub Med Coll Abbottabad; 2012; 24(2):54-7. PubMed ID: 24397053
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow cellularity MRI calculation and correlation with bone marrow biopsy.
Matcuk GR; Siddiqi I; Cen S; Hagiya A; Isaacson R; Brynes R
Clin Imaging; 2016; 40(3):392-7. PubMed ID: 27133674
[TBL] [Abstract][Full Text] [Related]
36. A review of histology of bone marrow trephine in malignant lymphomas.
Durosinmi MA; Mabayoje VO; Akinola NO
Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193
[TBL] [Abstract][Full Text] [Related]
37. Bone, bone marrow, and MIBI scintigraphic findings in Gaucher's disease "bone crisis".
Blocklet D; Abramowicz M; Schoutens A
Clin Nucl Med; 2001 Sep; 26(9):765-9. PubMed ID: 11507294
[TBL] [Abstract][Full Text] [Related]
38. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
39. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look.
Ebie N; Loew JM; Gregory SA
Hematol Pathol; 1989; 3(1):29-33. PubMed ID: 2745358
[TBL] [Abstract][Full Text] [Related]
40. F-18 FDG PET for evaluation of bone marrow involvement in non-Hodgkin lymphoma: a meta-analysis.
Chen YK; Yeh CL; Tsui CC; Liang JA; Chen JH; Kao CH
Clin Nucl Med; 2011 Jul; 36(7):553-9. PubMed ID: 21637057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
